miR-221/222 Confers Radioresistance in Glioblastoma Cells Through Activating Akt Independent of PTEN Status

被引:75
|
作者
Li, W. [1 ]
Guo, F. [2 ]
Wang, P. [1 ]
Hong, S. [1 ]
Zhang, C. [1 ]
机构
[1] Tianjin Huanhu Hosp, Dept Radiat Oncol, Tianjin 300060, Peoples R China
[2] Tianjin Med Univ, Gen Hosp, Dept Gynecol & Obstet, Tianjin 300052, Peoples R China
关键词
Glioblastoma; radiosensitivity; miR-221; DDR; Akt; DNA-DAMAGE RESPONSE; IONIZING-RADIATION; PROSTATE-CANCER; GLIOMA; RADIOTHERAPY; MICRORNA; GROWTH; INHIBITION; MODULATION; EXPRESSION;
D O I
10.2174/1566524013666131203103147
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glioblastoma is highly resistant to radiation therapy. The underlying molecular mechanism is not completely understood. The DNA damage response (DDR) pathway plays a crucial role in radioresistance of glioablastoma cells. Growing evidence has demonstrated that radiation induces alterations in microRNA (miR) profiles. However, how radiation induces specific miRs and how they might regulate the DDR remain elusive. In our study, we found that radiation induced c-jun transcription of miR-221 and miR-222. miR-221 and miR-222 modulated DNA-PKcs expression to affect DNA damage repair by activating Akt independent of PTEN status. Knocking down of miR-221/222 significantly increased radiosensitivity of glioblastoma cells. Inhibition of Akt by RNAi or LY294002 treatment may overcome miR-221/222 induced radioresistance. Notably, combined anti-miR-221/222 and radiotherapy has remarkably inhibited tumor growth compared with anti-miR-221/222 or radiotherapy alone in a subcutaneous mouse model. Our results suggest that radio-induced c-jun promotes transcription of miR-221/222, which mediates DNA damage repair of glioblastoma cells independent of PTEN. These data indicate for the first time that miR-221/222 play an important role in mediating radio-induced DNA damage repair and that miR-221/222 could serve as potential therapeutic targets for increasing radiosensitivity of glioblastoma cells.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 50 条
  • [1] Knocked down miR-221/222 inhibits Akt pathway to suppress malignant glioma cell growth independent of PTEN status
    Zhang, Chunzhi
    Zhang, Anling
    Hao, Jianwei
    Zhang, Junxia
    Jia, Zhifan
    Wang, Guangxiu
    Pu, Peiyu
    Kang, Chunsheng
    CANCER RESEARCH, 2011, 71
  • [2] miR-221/222 promote malignant progression of glioma through activation of the Akt pathway
    Zhang, Junxia
    Han, Lei
    Ge, Youlin
    Zhou, Xuan
    Zhang, Anling
    Zhang, Chunzhi
    Zhong, Yue
    You, Yongping
    Pu, Peiyu
    Kang, Chunsheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (04) : 913 - 920
  • [3] miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells
    Hao, Jianwei
    Zhang, Chunzhi
    Zhang, Anlin
    Wang, Kun
    Jia, Zhifan
    Wang, Guangxiu
    Han, Lei
    Kang, Chunsheng
    Pu, Peiyu
    ONCOLOGY REPORTS, 2012, 27 (05) : 1504 - 1510
  • [4] MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
    Zhang, Chun-Zhi
    Zhang, Jun-Xia
    Zhang, An-Ling
    Shi, Zhen-Dong
    Han, Lei
    Jia, Zhi-Fan
    Yang, Wei-Dong
    Wang, Guang-Xiu
    Jiang, Tao
    You, Yong-Ping
    Pu, Pei-Yu
    Cheng, Jin-Quan
    Kang, Chun-Sheng
    MOLECULAR CANCER, 2010, 9
  • [5] MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
    Chun-Zhi Zhang
    Jun-Xia Zhang
    An-Ling Zhang
    Zhen-Dong Shi
    Lei Han
    Zhi-Fan Jia
    Wei-Dong Yang
    Guang-Xiu Wang
    Tao Jiang
    Yong-Ping You
    Pei-Yu Pu
    Jin-Quan Cheng
    Chun-Sheng Kang
    Molecular Cancer, 9
  • [6] Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN
    Zhou, Lijie
    Jiang, Fangfang
    Chen, Xijuan
    Liu, Zifeng
    Ouyang, Ying
    Zhao, Wei
    Yu, Dongsheng
    ONCOLOGY LETTERS, 2016, 12 (06) : 4419 - 4426
  • [7] RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway (Retracted Article)
    Li, Bailong
    Lu, Ying
    Wang, Honghai
    Han, Xiaocui
    Mao, Jun
    Li, Jiazhi
    Yu, Lihui
    Wang, Bo
    Fan, Shujun
    Yu, Xiaotang
    Song, Bo
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 93 - 101
  • [8] MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway
    Amini-Farsani, Zeinab
    Sangtarash, Mohammad Hossein
    Shamsara, Mehdi
    Teimori, Hossein
    CYTOTECHNOLOGY, 2018, 70 (01) : 203 - 213
  • [9] MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway
    Zeinab Amini-Farsani
    Mohammad Hossein Sangtarash
    Mehdi Shamsara
    Hossein Teimori
    Cytotechnology, 2018, 70 : 203 - 213
  • [10] miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
    Quintavalle, Cristina
    Mangani, Davide
    Roscigno, Giuseppina
    Romano, Giulia
    Diaz-Lagares, Angel
    Iaboni, Margherita
    Donnarumma, Elvira
    Fiore, Danilo
    De Marinis, Pasqualino
    Soini, Ylermi
    Esteller, Manel
    Condorelli, Gerolama
    PLOS ONE, 2013, 8 (09):